基本信息
浏览量:107
职业迁徙
个人简介
Research Summary:
Ductal carcinoma in situ (DCIS) represents 20 – 40% of newly diagnosed breast cancers. DCIS itself is not life threatening, however some women with DCIS will develop life-threatening invasive breast cancer. At the present time, we are unable to identify which women will progress to invasive cancer due to small sample size in many studies and variable pathologic evaluation of specimens. Therefore, all women with DCIS undergo surgical treatment often followed by radiation.
This study will establish the largest cohort of DCIS in the world and will be the only population-based study of DCIS with full description of treatment and outcomes and will include complete pathology review. The results of this study will help identify women with DCIS at greatest risk of recurrence, and will facilitate targeting of treatments to those at risk while avoiding unnecessary morbidity for the majority of women with DCIS who will never die of breast cancer.
Ductal carcinoma in situ (DCIS) represents 20 – 40% of newly diagnosed breast cancers. DCIS itself is not life threatening, however some women with DCIS will develop life-threatening invasive breast cancer. At the present time, we are unable to identify which women will progress to invasive cancer due to small sample size in many studies and variable pathologic evaluation of specimens. Therefore, all women with DCIS undergo surgical treatment often followed by radiation.
This study will establish the largest cohort of DCIS in the world and will be the only population-based study of DCIS with full description of treatment and outcomes and will include complete pathology review. The results of this study will help identify women with DCIS at greatest risk of recurrence, and will facilitate targeting of treatments to those at risk while avoiding unnecessary morbidity for the majority of women with DCIS who will never die of breast cancer.
研究兴趣
论文共 221 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Cancer Researchno. 9_Supplement (2024): PO4-13
CURRENT ONCOLOGYno. 2 (2024): 975-986
Journal of clinical oncology official journal of the American Society of Clinical Oncologyno. 27 (2024): 3196-3206
Cancer Researchno. 9_Supplement (2024): PO5-18
S. Lu,E. Rakovitch,B. Hannon,C. Zimmermann,M. Yan,J. de Almeida,C. M. Yao,E. F. Gillespie, F. Chino,D. Yerramilli,F. Abdel-Rahman, H. Othman, S. Mheid,C. J. Tsai
International Journal of Radiation OncologyBiologyPhysicsno. 2 (2023)
CANCER RESEARCHno. 5 (2023)
Practical radiation oncology (2023)
CANCER RESEARCHno. 5 (2023)
加载更多
作者统计
#Papers: 219
#Citation: 5154
H-Index: 38
G-Index: 69
Sociability: 7
Diversity: 3
Activity: 41
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn